Daniel R. Chevallard
Chief Financial Officer · LENZ Therapeutics, Inc.
- 2025
- Mar 30, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel R. Chevallard files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shawn Olsson - $261K in LENZ purchases and sales in the last 12 months
- Evert B. Schimmelpennink - $251K in LENZ purchases and sales in the last 12 months
- James W. McCollum - $239K in LENZ purchases and sales in the last 12 months
- Jeffrey P. George - $50K in LENZ purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daniel R. Chevallard?
Daniel R. Chevallard is a corporate insider, tracked as Chief Financial Officer of LENZ Therapeutics, Inc. (LENZ). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Daniel R. Chevallard last file a Form 4?
The most recent primary Form 4 on record is dated 30 March 2026, one of 2 filings going back to 2025.
Has Daniel R. Chevallard been buying or selling stock?
Recorded transactions: 3 open-market purchases ($114K) and 0 open-market sales across all tracked filings.
